Delcath Systems Inc. DCTH
$11.62
▼ -0.38% 24H
About
Delcath Systems Inc. is a medical device company focused on providing treatment options for primary and metastatic liver cancers through its innovative technologies. Central to their product offerings is the percutaneous hepatic perfusion (PHP) system, which enables targeted delivery of high-dose chemotherapy directly …
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees96
TickerDCTH
Statistics
Market Cap$400.5M
Revenue (TTM)$85.2M
Net Income$2.7M
Net Margin3.2%
EPS$0.07
P/E1176.50
P/S4.49
P/B3.60
EV/EBITDA-225.34
ROE0.6%
Dividend Yield—
Price$11.62
Data: Twelve Data · Revenue = mcap / P/S